Levocetirizine and montelukast in the COVID-19 treatment paradigm.
Int Immunopharmacol. 2022 Feb;103:108412. doi: 10.1016/j.intimp.2021.108412. Epub 2021 Dec 15.
Int Immunopharmacol. 2022.
PMID: 34942461
Free PMC article.